SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Biocon - Quaterly Results

14 Feb 2023 Evaluate
A fair growth of 17.34% in the revenue at Rs. 5550.00 millions was reported in the December 2022 quarter as compared to Rs. 4730.00 millions during year-ago period.Good  Net Profit growth of 38.04% reported above the corresponding previous quarter figure of Rs. 255.00 millions to Rs. 352.00 millioins.OP of the company witnessed a marginal growth to 970.00 millions from 710.00 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 5550.00 4730.00 17.34 14862.00 12205.00 21.77 17382.00 20284.00 -14.31
Other Income 599.00 367.00 63.22 2074.00 1264.00 64.08 1872.00 1502.00 24.63
PBIDT 970.00 710.00 36.62 2749.00 1610.00 70.75 2483.00 4627.00 -46.34
Interest 214.00 1.00 21300.00 215.00 4.00 5275.00 4.00 4.00 0.00
PBDT 756.00 709.00 6.63 12626.00 1606.00 686.18 2479.00 4623.00 -46.38
Depreciation 291.00 276.00 5.43 875.00 801.00 9.24 1082.00 1035.00 4.54
PBT 465.00 433.00 7.39 11751.00 805.00 1359.75 1397.00 3588.00 -61.06
TAX 113.00 178.00 -36.52 1375.00 325.00 323.08 536.00 783.00 -31.55
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 352.00 255.00 38.04 10376.00 480.00 2061.67 861.00 2805.00 -69.30
Equity 6003.00 6003.00 0.00 6003.00 6003.00 0.00 6003.00 6000.00 0.05
PBIDTM(%) 17.48 15.01 16.43 18.50 13.19 40.22 14.28 22.81 -37.38

Biocon Share Price

380.55 -2.05 (-0.54%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×